AI-generated summary
The authors retrospectively reviewed 96 patients who received aminolevulinic acid photodynamic therapy for photodamage, combined with blue light and various red light, pulsed-dye laser, or intense pulsed light sources. They report no significant differences in patient-reported improvement or adverse events between treatment arms, with a trend toward greater efficacy for multi-source treatment. Recall bias and unequal group sizes limit the findings.
- Participants
- 96
- Who or what was studied
- Ninety-six patients (121 treatments) with photodamage treated from 2001 to 2010 at a single center
- Limits stated in the abstract
- Retrospective design with potential recall bias, widely disparate group sizes, and unequal follow-up times between patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Photodynamic therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.